Cargando…

Intranasal delivery of darunavir improves brain drug concentrations in mice for effective HIV treatment

Despite the availability of combined antiretroviral therapy (cART), which reduces the HIV replication in chronically HIV-infected patients, HIV associated neurocognitive disorders (HAND) persists in the brain. The blood-brain barrier (BBB) is the major barrier for the penetration of drugs including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Asit, Zhou, Lina, Godse, Sandip, Sinha, Namita, Ma, Dejian, Parmar, Keyur, Kumar, Santosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747527/ https://www.ncbi.nlm.nih.gov/pubmed/36532875 http://dx.doi.org/10.1016/j.bbrep.2022.101408

Ejemplares similares

Curcumin enhances elvitegravir concentration and alleviates oxidative stress and inflammatory response
por: Godse, Sandip, et al.
Publicado: (2023)

Curcumin enhances elvitegravir concentration and alleviates oxidative stress and inflammatory response
por: Godse, Sandip, et al.
Publicado: (2023)

Extracellular vesicles released from macrophages modulates interleukin-1β in astrocytic and neuronal cells
por: Kodidela, Sunitha, et al.
Publicado: (2023)

Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality
por: Kodidela, Sunitha, et al.
Publicado: (2022)

Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations
por: Gutierrez‐Valencia, Alicia, et al.
Publicado: (2018)

Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting
por: Daskapan, Alper, et al.
Publicado: (2017)

Anti-HIV Activity of Cucurbitacin-D against Cigarette Smoke Condensate-Induced HIV Replication in the U1 Macrophages
por: Kodidela, Sunitha, et al.
Publicado: (2021)

Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles
por: Zhou, Lina, et al.
Publicado: (2022)

Resveratrol and its analogs suppress HIV replication, oxidative stress, and inflammation in macrophages
por: Kumar, Santosh, et al.
Publicado: (2023)

Effect of benzo(a)pyrene on oxidative stress and inflammatory mediators in astrocytes and HIV-infected macrophages
por: Kumar, Asit, et al.
Publicado: (2022)

Intranasal Delivery of Darunavir-Loaded Mucoadhesive In Situ Gel: Experimental Design, In Vitro Evaluation, and Pharmacokinetic Studies
por: Nair, Anroop B., et al.
Publicado: (2022)

Circulatory Astrocyte and Neuronal EVs as Potential Biomarkers of Neurological Dysfunction in HIV-Infected Subjects and Alcohol/Tobacco Users
por: Kodidela, Sunitha, et al.
Publicado: (2020)

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily
por: Zorrilla, CD, et al.
Publicado: (2014)

Combating HIV resistance – focus on darunavir
por: Tremblay, Cécile L
Publicado: (2008)

Role of darunavir in the management of HIV infection
por: Lascar, R Monica, et al.
Publicado: (2009)

Structures of Darunavir-Resistant HIV-1 Protease Mutant Reveal Atypical Binding of Darunavir to Wide Open Flaps
por: Zhang, Ying, et al.
Publicado: (2014)

Risk factors contributing to a low darunavir plasma concentration
por: Daskapan, Alper, et al.
Publicado: (2017)

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance
por: Wolf, Eva, et al.
Publicado: (2021)

Profile of darunavir in the management of treatment-experienced HIV patients
por: Wolfe, Cameron, et al.
Publicado: (2009)

Darunavir-based dual therapy in HIV experienced patients
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Darunavir in experienced patients
por: Sterrantino, G, et al.
Publicado: (2010)

Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients: Observational Data from the Randomized POTENT Trial
por: Elgadi, Mabrouk M., et al.
Publicado: (2012)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavir: Various toxicities and off-label use: 9 case reports
Publicado: (2020)

Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients
por: Dobroszycki, Joanna, et al.
Publicado: (2011)

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data
por: Daskapan, Alper, et al.
Publicado: (2019)

Effects of Cigarette Smoke Condensate on Oxidative Stress, Apoptotic Cell Death, and HIV Replication in Human Monocytic Cells
por: Rao, PSS, et al.
Publicado: (2016)

Potential for intranasal drug delivery to alter cerebrospinal fluid outflow via the nasal turbinate lymphatics
por: Kim, Harold, et al.
Publicado: (2014)

Induction of cytokines in different organs after intranasal inoculation of Campylobacter jejuni in mice
por: Al-Banna, Nadia A, et al.
Publicado: (2012)

Nicotine self-administration with menthol and audiovisual cue facilitates differential packaging of CYP2A6 and cytokines/chemokines in rat plasma extracellular vesicles
por: Kumar, Asit, et al.
Publicado: (2021)

CSF and Blood Oxytocin Concentration Changes following Intranasal Delivery in Macaque
por: Dal Monte, Olga, et al.
Publicado: (2014)

Molecular designing and in silico evaluation of darunavir derivatives as anticancer agents
por: Mahto, Manoj kumar, et al.
Publicado: (2014)

Benzo(a)pyrene in Cigarette Smoke Enhances HIV-1 Replication through NF-κB Activation via CYP-Mediated Oxidative Stress Pathway
por: Ranjit, Sabina, et al.
Publicado: (2018)

Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir
por: Neely, Michael, et al.
Publicado: (2009)

Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS
por: Putcharoen, Opass, et al.
Publicado: (2015)

Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
por: Chavda, Vivek P., et al.
Publicado: (2021)

Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice
por: Santamaria, Giulia, et al.
Publicado: (2020)

The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms
por: Gao, Xiaobo, et al.
Publicado: (2019)

Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders
por: Latronico, Tiziana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qj9h96bsh06e9i7kpbr14jvb1m